Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Compounds interacting with nicotinic receptors for cognitive and memory deficits

Sep. 2, 1998

Anticonvulsant benzamides prepared at SKB

Sep. 2, 1998

Cambridge NeuroScience announces advances in MS program

Sep. 2, 1998

Betaseron to receive fast track review in Canada

Sep. 2, 1998

Lamotrigine approved for new indication in the U.S.: Lennox-Gastaut syndrome

Sep. 2, 1998

PD-165167 shows excellent selectivity for dopamine D4 receptors

Sep. 1, 1998

Vertex, Schering AG form strategic alliance to develop neurologic drugs

Aug. 31, 1998

Orion and Novartis agree on the distribution of entacapone

Aug. 31, 1998

Results of phase II study support efficacy of (S)-fluoxetine as a treatment for migraine

Aug. 31, 1998

News from the ACS: Lilly investigates antioxidants for treating neuronal injury

Aug. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...